Patents Assigned to Molecular Technologies, Inc.
  • Patent number: 11666907
    Abstract: This document provides methods, devices, and systems for detecting the presence, absence, or amount of one or more analytes. For example, this document provides methods for using graphene-based sensors to detect one or more analytes (e.g., proteins, nucleic acids, intact cells, intact viruses, intact microorganisms, and/or chemicals).
    Type: Grant
    Filed: September 28, 2018
    Date of Patent: June 6, 2023
    Assignee: GRIP Molecular Technologies, Inc.
    Inventors: John Lalonde, Bruce Edgar Batten
  • Patent number: 11639356
    Abstract: Provided are compounds of formula (I): or cosmeceutically acceptable or pharmaceutically acceptable salts thereof. Additionally provided are cosmeceutical and/or pharmaceutical compositions comprising the compounds of formula (I), or the cosmeceutically acceptable or pharmaceutically acceptable salts thereof. Also provided are therapeutic and/or cosmetic methods using the cosmeceutical and/or pharmaceutical compositions comprising the compounds of formula (I), or the cosmeceutically acceptable or pharmaceutically acceptable salts thereof, for modulating cyclic adenosine monophosphate response element binding (CREB)-binding protein (CBP)/?-catenin mediated signaling in treating skin related diseases, conditions, or disorders mediated by aberrant CBP/?-catenin signaling and cosmetic methods for treating skin conditions mediated by aberrant CBP/?-catenin signaling.
    Type: Grant
    Filed: October 1, 2021
    Date of Patent: May 2, 2023
    Assignee: Genesis Molecular Technologies, Inc.
    Inventor: Fuqiang Ruan
  • Patent number: 7800070
    Abstract: A camera sub-module is provided for providing tomographic imaging of radiation emissions generated internally by a body. The camera sub-module includes a radiation-emitting layer having a radioactive source for emitting transmission emissions, and at least one radiation-detection layer for contemporaneously detecting and permitting differentiation between the transmission emissions and emissions generated internal to an imaged body administered with a positron-emitting radiotracer. Also provided herein are imaging systems, scanners, and other apparatus and methods.
    Type: Grant
    Filed: April 10, 2007
    Date of Patent: September 21, 2010
    Assignee: Quantum Molecular Technologies, Inc.
    Inventors: Irving Weinberg, Valeri Saveliev
  • Patent number: 7132540
    Abstract: The present invention discloses a series of novel hindered spiro-ketal nitroxides prepared by the ketalization reaction of 1,3-propanediols with triacetoneamine followed by oxidation. These novel spiro-ketals have unexpected advantages in hydrocarbon and monomer solubility which is important in styrene processing and refinery stream inhibition. Further, the invention shows an unexpected advantage over commercially available nitroxides in hydrocarbon solubility, especially in styrene and hydrocarbons. This invention also shows that these novel spiro-nitroxides are capable of inhibiting vinyl and acrylate polymerizations using an effective inhibition concentration of the nitroxide of the present invention.
    Type: Grant
    Filed: September 27, 2004
    Date of Patent: November 7, 2006
    Assignee: Nova Molecular Technologies Inc.
    Inventors: Mikolaj Jawdosiuk, George Sosnovsky, Jon Michael Clumpner, Anthony J. O'Lenick, Jr.
  • Patent number: 7045281
    Abstract: Division arrested cells are used in screening assays to determine the effect of a substance of interest on the cells. The division arrested cells can be used in drug screening assays, signal transduction assays, and are especially useful in large scale, high throughput assays.
    Type: Grant
    Filed: September 20, 2002
    Date of Patent: May 16, 2006
    Assignee: Cell & Molecular Technologies, Inc.
    Inventors: Thomas Livelli, Zhong Zhong, Mark Federici, Mei Cong
  • Patent number: 7022872
    Abstract: The invention relates to a method for preparing F-Dopa and 18F-Dopa and intermediates that are useful in the method. The invention is a method that synthesizes F-Dopa and 18F-Dopa in good yield with high enantiopurity without the need for further transformations. The method includes the step of reacting a benzaldehyde derivative with a phosphonic acid derivative to produces an olefin intermediate that can be asymmetrically hydrogenated to produce the desired enantiomer.
    Type: Grant
    Filed: December 19, 2003
    Date of Patent: April 4, 2006
    Assignee: Molecular Technologies, Inc.
    Inventors: Joseph C. Walsh, Henry C. Padgett
  • Publication number: 20040262158
    Abstract: A beta detector assembly for use in the synthesis and analysis of radiopharmaceuticals, such as in microfluidic radiochromatography. The beta detector assembly includes a base, preferably fabricated from glass so as to take advantage of electroosmotic flow, that serves as the body of the beta detector assembly. A microfluidic channel passes through the length of the base. A solid-state charge particle detector, for detecting beta particles, is provided and is positioned with respect to the base so as to receive beta particles. A portion of the base is disposed between the microfluidic channel and the solid-state charge particle detector and has a thickness that is selected to substantially allow transmission of beta particles there thru for detection by the charge particle detector. In one embodiment, the base is fabricated of glass. In another embodiment, the base is fabricated of silicon such that the base and the solid-state charge particle detector are integral.
    Type: Application
    Filed: April 21, 2004
    Publication date: December 30, 2004
    Applicant: Molecular Technologies, Inc.
    Inventors: Charles W. Alvord, Charles Russell Buchanan, Joseph C. Matteo, Henry Clifton Padgett, Thomas Lee Collier
  • Publication number: 20040258615
    Abstract: The invention provides a method and apparatus for preparation of radiochemicals wherein the reaction that couples the radioactive isotope to the reactive precursor to form a positron-emitting molecular imaging probe is performed in a microfluidic environment.
    Type: Application
    Filed: April 20, 2004
    Publication date: December 23, 2004
    Applicant: Molecular Technologies, Inc.
    Inventors: Charles Russell Buchanan, Henry C. Padgett, Thomas Lee Collier, Joseph C. Matteo, Charles W. Alvord
  • Patent number: 6458999
    Abstract: The present invention is related to a series of derivatives of novel ether diamine compounds prepared by the cyanobutylation reaction of an alcohol having 3 to 22 carbon atoms with 2-pentenenitrile to form a branched alkyl ether nitrile. The etheraminonitriles formed by the process are hydrogenated to form alkylether amines. The resulting product can be reacted with 2-pentenenitrile and or acrylonitrile and in a subsequent step, hydrogenated to yield a diamine. Specifically, the present invention deals with two types of tertiary amines one made by the reaction of novel ether diamines compounds with ethylene oxide, propylene oxide or butylene oxide or mixtures thereof, producing alkoxylated tertiary amines and the other made by the reaction of novel ether amine compounds with formaldehyde and hydrogen producing methylated tertiary amines. The invention also disclosed novel amine oxides, and quaternary compounds made from said tertiary amines.
    Type: Grant
    Filed: November 27, 2000
    Date of Patent: October 1, 2002
    Assignee: Nova Molecular Technologies INC
    Inventors: Thomas J. Daly, Michael Clumpner, Anthony J. O'Lenick, Jr.
  • Patent number: 6426436
    Abstract: The present invention is related to a series of derivatives of novel ether diamine compounds prepared by the cynobutylation reaction of an alcohol having 3 to 22 carbon atoms with 2-pentenenitrile to form a branched alkyl ether nitrile. The etheraminonitriles formed by the process are hydrogenated to form alkylether amines. The resulting product can be reacted with 2-pentenenitrile and or acrylonitrile and in subsequent step, hydrogenated to yield a diamine. Specifically, the present invention deals with two types of tertiary amines one made by the reaction of novel ether diamines compounds with ethylene oxide, propylene oxide or butylene oxide or mixtures thereof, producing alkoxylated tertiary amines and the other made by the reaction of novel ether amine compounds with formaldehyde and hydrogen producing methylated tertiary amines. The invention also disclosed novel amine oxides, and quaternary compounds made from said tertiary amines.
    Type: Grant
    Filed: January 22, 2002
    Date of Patent: July 30, 2002
    Assignee: Nova Molecular Technologies Inc.
    Inventors: Thomas J. Daly, Michael Clumpner, Anthony J. O'Lenick, Jr.
  • Patent number: 6417401
    Abstract: The present invention is related to a series of derivatives of novel ether diamine compounds prepared by the cyanobutylation reaction of an alcohol having 3 to 22 carbon atoms with 2-pentenenitrile to form a branched alkyl ether nitrile. The etheraminonitriles formed by the process are hydrogenated to form alkylether amines. The resulting product can be reacted with 2-pentenenitrile and or acrylonitrile and in a subsequent step, hydrogenated to yield a diamine. Specifically, the present invention deals with two types of tertiary amines one made by the reaction of novel ether diamines compounds with ethylene oxide, propylene oxide or butylene oxide or mixtures thereof, producing alkoxylated tertiary amines and the other made by the reaction of novel ether amine compounds with formaldehyde and hydrogen producing methylated tertiary amines. The invention also disclosed novel amine oxides, and quaternary compounds made from said tertiary amines.
    Type: Grant
    Filed: January 22, 2002
    Date of Patent: July 9, 2002
    Assignee: Nova Molecular Technologies INC
    Inventors: Thomas J. Daly, Michael Clumpner, Anthony J. O'Lenick, Jr.
  • Patent number: 6331648
    Abstract: The present invention relates to a series of derivatives of novel ether amine compounds prepared by the cyanobutylation reaction of an alcohol having 3 to 22 carbon atoms with 2-pentenenitrile to form a branched alkyl ether nitrile. The alkyl ether nitrites formed by the process are hydrogenated to form alkylether amines. The resulting product can be reacted with 2-pentenenitrile and or acrylonitrile and in a subsequent step, hydrogenated to yield a diamine. Specifically, the present invention deals with two types of tertiary amines one made by the reaction of novel ether amine compounds with ethylene oxide, propylene oxide or butylene oxide or mixtures thereof producing alkoxylated tertiary amines and the other made by the reaction of novel ether amine compounds with formaldehyde and hydrogen producing methylated tertiary amines. The invention also discloses novel amine oxides, and quaternary compounds made from said tertiary amines.
    Type: Grant
    Filed: May 8, 2000
    Date of Patent: December 18, 2001
    Assignee: Nova Molecular Technologies INC
    Inventors: Thomas J. Daly, Michael Clumpner, Anthony J. O'Lenick, Jr.
  • Patent number: 6114585
    Abstract: The present invention relates to a series of novel ether amine compounds prepared by the cyanobutylation reaction of an alcohol having 12 to 26 carbon atoms with 2-pentenenitrile to form a branched alkyl ether nitrile. The etheraminonitriles formed by the process are hydrogenated to form alkylether amines. The resulting product can be reacted with 2-pentenenitrile and hydrogenated to yield a polyamine.
    Type: Grant
    Filed: December 13, 1999
    Date of Patent: September 5, 2000
    Assignee: Nova Molecular Technologies Inc
    Inventors: Thomas J. Daly, Anita Mokadam Sorhaug, Robert E. Harbour, Jr., Abraham A. Zahand, Michael Clumpner, Anthony J. O'Lenick, Jr.
  • Patent number: 5792619
    Abstract: An oxidative chromogenic reagent free from interference by bilirubin used for the measurement of a biogenic substance by an enzymatic analysis, which comprises a compound or a salt thereof represented by the following formula wherein R.sup.1 and R.sup.2 independently represent a C.sub.3-4 -alkly group substituted with a sulfonic acid group or a C.sub.3-4 -hydroxyalkyl group substituted with a sulfonic acid group; and R.sup.3 and R.sup.4 independently represent a C.sub.1-4 -alkyl group, a C.sub.1-4 -alkoxy group, a substituted or non-substituted carbamoyl group, an acyl-substituted amino group, an aryl group, or a halogen atom. The reagent is stable and has excellent water solubility, and it enables high sensitive and accurate measurement because interference by bilirubin is substantially reduced or eliminated.
    Type: Grant
    Filed: January 30, 1997
    Date of Patent: August 11, 1998
    Assignee: Dojindo Molecular Technologies, Inc.
    Inventor: Makoto Mizoguchi